Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Ainos, Inc. (AIMDW) Insider Trading Activity
Healthcare • Medical Devices • 46 employees
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Total Value
$350,190.19
Total Shares
751,634
Average Trade Value
$23,346.01
Most Active Insider
Tsai Chun Hsien
Total Activity: $115,956
Largest Single Transaction
$103,515
by Tsai Chun Hsien on Nov 26, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Director
|
Nov 26, 2024 | 208,797 | $96,047 | 323,900 (+64.5%) | Grant | |
Ceo, President, Chairman
Director, Officer
|
Nov 26, 2024 | 225,032 | $103,515 | 547,862 (+41.1%) | Grant | |
CFO
Officer
|
Nov 26, 2024 | 19,019 | $8,749 | 22,376 (+85.0%) | Grant | |
Director
|
Nov 26, 2024 | 204,721 | $94,172 | 327,432 (+62.5%) | Grant | |
CFO
Officer
|
Nov 22, 2024 | 4,000 | $1,840 | 7,357 (+54.4%) | Grant | |
Ceo, President, Chairman
Director, Officer
|
Nov 22, 2024 | 4,000 | $1,840 | 326,830 (+1.2%) | Grant | |
Director
|
Nov 22, 2024 | 4,000 | $1,840 | 119,103 (+3.4%) | Grant | |
Director
|
Nov 22, 2024 | 4,000 | $1,840 | 126,711 (+3.2%) | Grant | |
Director
|
Nov 15, 2024 | 4,200 | $1,848 | 122,711 (+3.4%) | Grant | |
Ceo, President, Chairman
Director, Officer
|
Nov 15, 2024 | 3,000 | $1,320 | 322,830 (+0.9%) | Grant | |
Director
|
Nov 15, 2024 | 4,200 | $1,848 | 115,103 (+3.6%) | Grant | |
Ceo, President, Chairman
Director, Officer
|
Sep 15, 2024 | 17,511 | $9,281 | 319,830 (+5.5%) | Grant | |
CFO
Officer
|
Sep 15, 2024 | 3,357 | $1,779 | 3,357 (+100.0%) | Grant | |
Director
|
Sep 15, 2024 | 23,280 | $12,338 | 118,511 (+19.6%) | Grant | |
Director
|
Sep 15, 2024 | 22,517 | $11,934 | 110,903 (+20.3%) | Grant |